Summary
The metabolic potency of recombinant human insulin-like growth factor II was studied in anaesthetized adult rats by obtaining dose-response curves for the hypoglycaemic action and for the stimulation of glucose metabolism during euglycaemic clamping. Compared to insulin, about 50 times higher doses of insulin-like growth factor II were required to result in identical in vivo responses, with half-maximally effective serum concentrations for the stimulation of glucose disposal during clamp studies of about 0.8 and 50 pmol/ml, respectively. A similar difference in potency was observed for the dose-dependent stimulatory actions on glucose metabolism in individual target tissues. Half-maximally effective serum concentrations in the range of 0.8 to 3.0 pmol/ml for insulin and of 40 to 70 pmol/ml for insulin-like growth factor II were seen to be required for 2-deoxyglucose uptake, glycogen formation in skeletal muscle and lipogenesis in epididymal fat. Maximal responses were identical with both peptides. These data suggest that in vivo acute metabolic actions of insulin-like growth factor II on carbohydrate metabolism occurred through insulin receptors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Froesch ER, Zapf J (1985) Insulin-like growth factors and insulin: comparative aspects. Diabetologia 28: 458–493
Humbel RE (1990) Insulin-like growth factors I and II. Eur J Biochem 190: 445–462
Schoenle E, Zapf J, Humbel RE, Froesch ER (1982) Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296: 252–253
Adams SO, Nissley SP, Handwerger S, Rechler MM (1983) Developmental patterns of insulin-like growth factor-I and -II synthesis and regulation in rat fibroblasts. Nature 302: 150–153
Brown AL, Graham DL, Nissley SP, Hill DJ, Strains AS, Rechler MM (1986) Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. J Biol Chem 261: 13144–13150
DeChiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78–80
Ashton IK, Zapf J, Einschenk I, MacKenzie IZ (1985) Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. Acta Endocrinol 110: 558–563
Froesch ER, Müller WA, Bürgi H, Waldvogel M, Labhart A (1966) Nonsuppressible insulin-like activity of human serum. II: biological properties of plasma extracts with nonsuppressible insulin-like activity. Biochem Biophys Acta 121: 360–374
Zapf J, Schoenle E, Froesch ER (1978) Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem 87: 285–296
Zapf J, Hauri C, Waldvogel M, Froesch ER (1986) Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors I and II in normal and hypophysectomized rats. J Clin Invest 77: 1768–1775
Douglas RG, Gluckman PD, Ball K, Breier B, Shaw JHF (1991) The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs. J Clin Invest 88: 614–622
Hyodo T, Megyesi K, Kahn CR, McLean JP, Friesen HG (1977) Adrenocortical carcinoma and hypoglycemia: evidence for production of nonsuppressible insulin-like activity by the tumor. J Clin Endocrinol Metab 44: 1175–1184
Daughaday WH, Trivedi B, Kapadia M (1981) Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycaemia. J Clin Endocrinol Metab 53: 289–294
Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P (1988) Insulin-like growth factor-II synthesis and secretion by a leiomyosarcoma with associated hypoglycaemia. N Engl J Med 319: 1434–1440
Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS (1990) Tumor hypoglycaemia: relationship to high molecular weight insulin-like growth factor-II. J Clin Invest 85: 1672–1679
Sinha MK, Buchanan C, Rainero-Maldonado C et al. (1990) IGF-II receptors and IGF-II-stimulated glucose transport in human fat cells. Am J Physiol 258: E534-E542
Czech MP (1989) Signal transmission by the insulin-like growth factors. Cell 59: 235–238
Rechler MM, Nissley SP (1985) The nature and regulation of the receptors for insulin-like growth factors. Ann Rev Physiol 47: 425–442
Hartmann H, Meyer-Alber A, Braulke T (1992) Metabolic actions of insulin-like growth factor II in cultured adult rat hepatocytes are not mediated through the insulin-like growth factor II receptor. Diabetologia 35: 216–223
Vormbrock R (1974) UV-method with glucose dehydrogenase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, Vol 6. Verlag Chemie, Weinheim, pp 172–178
Yeh KC, Kwan KC (1978) A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J Pharmacokin Biopharm 6: 79–93
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
Kraegen EW, James DE, Jenkins AB, Chisholm DJ (1985) Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248: E353-E362
Kraegen EW, James DE, Storlien LH, Burleigh KM, Chisholm DJ (1986) In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 29: 192–198
Stansbie D, Brownsey RW, Crettaz M, Denton RM (1976) Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and adipose tissue of fed rats. Biochem J 160: 413–416
Keppler D, Decker K (1983) Glycogen. In: Bergmeyer HL, Bergmeyer J, Grassl M (eds) Methods of enzymatic analysis, Vol 6. Verlag Chemie, Weinheim, pp 11–18
Schmitz F, Hartmann H, Stümpel F, Creutzfeldt W (1991) In vivo metabolic action of insulin-like growth factor I in adult rats. Diabetologia 34: 144–149
Schoenle E, Zapf J, Hauri C, Steiner T, Froesch ER (1985) Comparison of in vivo effects of insulin-like growth factor I and II and of growth hormone in hypophysectomizedrats. Acta Endocrinol 108: 167–174
Zapf J, Walter H, Froesch ER (1981) Radioimmunological determination of insulinlike growth factor I and II in normal subjects and patients with growth disorders and extrapancreatic tumor hypoglycaemia. J Clin Invest 68: 1321–1330
Daughaday WH, Parker KA, Borowsky S, Trivedi B, Kapadia M (1982) Measurement of somatomedin-related peptides in fetal, neonatal and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity (MSA) after acid-ethanol extraction. Endocrinology 110: 575–581
Yang YW-H, Wang J-F, Orlowski CC, Nisseley SP, Rechler MM (1989) Structure, specificity, and regulation of the insulin-like growth factor-binding proteins in adult rat serum. Endocrinology 125: 1540–1555
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stümpel, F., Hartmann, H. Acute actions of insulin-like growth factor II on glucose metabolism in adult rats. Diabetologia 35, 932–938 (1992). https://doi.org/10.1007/BF00401421
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401421